UniProt ID | CRKL_HUMAN | |
---|---|---|
UniProt AC | P46109 | |
Protein Name | Crk-like protein | |
Gene Name | CRKL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 303 | |
Subcellular Localization | ||
Protein Description | May mediate the transduction of intracellular signals.. | |
Protein Sequence | MSSARFDSSDRSAWYMGPVSRQEAQTRLQGQRHGMFLVRDSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKIGDQEFDHLPALLEFYKIHYLDTTTLIEPAPRYPSPPMGSVSAPNLPTAEDNLEYVRTLYDFPGNDAEDLPFKKGEILVIIEKPEEQWWSARNKDGRVGMIPVPYVEKLVRSSPHGKHGNRNSNSYGIPEPAHAYAQPQTTTPLPAVSGSPGAAITPLPSTQNGPVFAKAIQKRVPCAYDKTALALEVGDIVKVTRMNINGQWEGEVNGRKGLFPFTHVKIFDPQNPDENE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Methylation | ARFDSSDRSAWYMGP CCCCCCCCCCCCCCC | 30.17 | - | |
15 | Phosphorylation | SSDRSAWYMGPVSRQ CCCCCCCCCCCCCHH | 7.60 | 23917254 | |
41 | Phosphorylation | GMFLVRDSSTCPGDY CEEEEECCCCCCCCE | 19.58 | 22167270 | |
42 | Phosphorylation | MFLVRDSSTCPGDYV EEEEECCCCCCCCEE | 38.01 | 23401153 | |
43 | Phosphorylation | FLVRDSSTCPGDYVL EEEECCCCCCCCEEE | 27.03 | 22167270 | |
44 | Glutathionylation | LVRDSSTCPGDYVLS EEECCCCCCCCEEEE | 3.71 | 22555962 | |
48 | Phosphorylation | SSTCPGDYVLSVSEN CCCCCCCEEEEEECC | 14.81 | 23663014 | |
51 | Phosphorylation | CPGDYVLSVSENSRV CCCCEEEEEECCCCE | 17.35 | 23663014 | |
53 | Phosphorylation | GDYVLSVSENSRVSH CCEEEEEECCCCEEE | 27.90 | 23403867 | |
56 | Phosphorylation | VLSVSENSRVSHYII EEEEECCCCEEEEEE | 29.97 | 23403867 | |
59 | Phosphorylation | VSENSRVSHYIINSL EECCCCEEEEEECCC | 14.95 | 28152594 | |
61 | Phosphorylation | ENSRVSHYIINSLPN CCCCEEEEEECCCCC | 8.94 | 28152594 | |
92 | Phosphorylation | LEFYKIHYLDTTTLI HHHHEEEEEECCCCC | 15.11 | 23090842 | |
95 | Phosphorylation | YKIHYLDTTTLIEPA HEEEEEECCCCCCCC | 21.05 | 23090842 | |
96 | Phosphorylation | KIHYLDTTTLIEPAP EEEEEECCCCCCCCC | 21.19 | 23090842 | |
97 | Phosphorylation | IHYLDTTTLIEPAPR EEEEECCCCCCCCCC | 28.03 | 23090842 | |
105 | Phosphorylation | LIEPAPRYPSPPMGS CCCCCCCCCCCCCCC | 13.65 | 30278072 | |
107 | Phosphorylation | EPAPRYPSPPMGSVS CCCCCCCCCCCCCCC | 32.47 | 23401153 | |
110 | Sulfoxidation | PRYPSPPMGSVSAPN CCCCCCCCCCCCCCC | 7.69 | 30846556 | |
112 | Phosphorylation | YPSPPMGSVSAPNLP CCCCCCCCCCCCCCC | 13.47 | 30278072 | |
114 | Phosphorylation | SPPMGSVSAPNLPTA CCCCCCCCCCCCCCH | 39.44 | 25159151 | |
120 | O-linked_Glycosylation | VSAPNLPTAEDNLEY CCCCCCCCHHHHHHH | 45.93 | OGP | |
120 | Phosphorylation | VSAPNLPTAEDNLEY CCCCCCCCHHHHHHH | 45.93 | 30108239 | |
127 | Phosphorylation | TAEDNLEYVRTLYDF CHHHHHHHEEEHHCC | 9.82 | 22115753 | |
130 | Phosphorylation | DNLEYVRTLYDFPGN HHHHHEEEHHCCCCC | 21.45 | 25106551 | |
132 | Phosphorylation | LEYVRTLYDFPGNDA HHHEEEHHCCCCCCH | 18.22 | 20007894 | |
145 | Acetylation | DAEDLPFKKGEILVI CHHHCCCCCCEEEEE | 58.91 | 25953088 | |
145 | Ubiquitination | DAEDLPFKKGEILVI CHHHCCCCCCEEEEE | 58.91 | 32015554 | |
172 | Sulfoxidation | NKDGRVGMIPVPYVE CCCCCEEEEECHHHH | 2.61 | 30846556 | |
177 | Phosphorylation | VGMIPVPYVEKLVRS EEEEECHHHHHHHHC | 22.83 | 27362937 | |
180 | Acetylation | IPVPYVEKLVRSSPH EECHHHHHHHHCCCC | 42.09 | 30587891 | |
180 | Ubiquitination | IPVPYVEKLVRSSPH EECHHHHHHHHCCCC | 42.09 | 24816145 | |
184 | Phosphorylation | YVEKLVRSSPHGKHG HHHHHHHCCCCCCCC | 40.52 | 23898821 | |
185 | Phosphorylation | VEKLVRSSPHGKHGN HHHHHHCCCCCCCCC | 15.45 | 25849741 | |
195 | Phosphorylation | GKHGNRNSNSYGIPE CCCCCCCCCCCCCCC | 24.74 | 21945579 | |
197 | Phosphorylation | HGNRNSNSYGIPEPA CCCCCCCCCCCCCCC | 25.26 | 21945579 | |
198 | Phosphorylation | GNRNSNSYGIPEPAH CCCCCCCCCCCCCCC | 24.27 | 21945579 | |
207 | Phosphorylation | IPEPAHAYAQPQTTT CCCCCCCCCCCCCCC | 8.90 | 15268851 | |
212 | Phosphorylation | HAYAQPQTTTPLPAV CCCCCCCCCCCCCCC | 39.04 | 21945579 | |
213 | Phosphorylation | AYAQPQTTTPLPAVS CCCCCCCCCCCCCCC | 22.59 | 21945579 | |
214 | O-linked_Glycosylation | YAQPQTTTPLPAVSG CCCCCCCCCCCCCCC | 26.64 | OGP | |
214 | Phosphorylation | YAQPQTTTPLPAVSG CCCCCCCCCCCCCCC | 26.64 | 21945579 | |
220 | Phosphorylation | TTPLPAVSGSPGAAI CCCCCCCCCCCCCEE | 35.34 | 21945579 | |
222 | Phosphorylation | PLPAVSGSPGAAITP CCCCCCCCCCCEECC | 16.80 | 21945579 | |
228 | O-linked_Glycosylation | GSPGAAITPLPSTQN CCCCCEECCCCCCCC | 17.66 | OGP | |
228 | Phosphorylation | GSPGAAITPLPSTQN CCCCCEECCCCCCCC | 17.66 | 21945579 | |
232 | Phosphorylation | AAITPLPSTQNGPVF CEECCCCCCCCCCHH | 50.75 | 21945579 | |
233 | Phosphorylation | AITPLPSTQNGPVFA EECCCCCCCCCCHHH | 24.90 | 21945579 | |
251 | Phosphorylation | QKRVPCAYDKTALAL HHHCCCCCCCCEEEE | 25.37 | 27273156 | |
253 | Ubiquitination | RVPCAYDKTALALEV HCCCCCCCCEEEEEC | 24.03 | 29967540 | |
253 | Acetylation | RVPCAYDKTALALEV HCCCCCCCCEEEEEC | 24.03 | 23749302 | |
254 | Phosphorylation | VPCAYDKTALALEVG CCCCCCCCEEEEECC | 24.81 | 28152594 | |
283 | Ubiquitination | EGEVNGRKGLFPFTH EEEECCCCCEEECEE | 62.45 | 29967540 | |
292 | Ubiquitination | LFPFTHVKIFDPQNP EEECEEEEECCCCCC | 30.01 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
207 | Y | Phosphorylation | Kinase | BCR-ABL1 | A9UF07 | PSP |
207 | Y | Phosphorylation | Kinase | ABL1 | P00519 | PhosphoELM |
207 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:12671687 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CRKL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CRKL_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-127, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132; TYR-207 ANDTYR-251, AND MASS SPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-132 AND TYR-198, ANDMASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-207 AND TYR-251, ANDMASS SPECTROMETRY. |